Prevail是一家生物技术公司,致力于为神经退行性疾病患者开发潜在的基于疾病改良AAV9的基因疗法。#生物医药下一个十年# #AAV基因治疗#查看全文
消灵通2020-12-15 22:44
$Prevail Therapeutics(PRVL)$ $礼来(LLY)$ 礼来上涨2%,Prevail Therapeutics飙涨83%;礼来宣布以8.8亿美元或每股22.5美元的价格收购Prevail Therapeutics。查看全文
牛唐2020-12-15 21:55
$礼来(LLY)$ Buy $Prevail Therapeutics(PRVL)$ for $22.50/Share in Cash ,一天一个并购,$美国生科ETF-SPDR(XBI)$ 又要嗨了查看全文
华尔街操盘手_2019-06-21 00:15
$Slack Technologies(WORK)$ $Grocery Outlet(GO)$ $Prevail Therapeutics(PRVL)$ 最全ipo上市列表 网页链接查看全文
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-20-006007 Act: 34 Size: 5 MB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-20-004748 Act: 34 Size: 27 KB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-19-323101 Act: 34 Size: 26 KB 网页链接
$Prevail Therapeutics(PRVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-057001 Size: 5 KB 网页链接
$Prevail Therapeutics(PRVL)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-19-056998 Size: 6 KB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-19-294797 Act: 34 Size: 37 KB 网页链接
$Prevail Therapeutics(PRVL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-19-042732 Act: 34 Size: 7 MB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-19-042617 Act: 34 Size: 267 KB 网页链接
$Prevail Therapeutics(PRVL)$ 8-K - Current report Filed: 2019-10-08 AccNo: 0001193125-19-264057 Size: 36 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Prevail Therapeutics(PRVL)$ 8-K - Current report Filed: 2019-09-10 AccNo: 0001193125-19-242120 Size: 26 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接